{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:37:57Z","timestamp":1774535877831,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1111\/igc.0b013e3181a3cc94","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:53:16Z","timestamp":1291384396000},"page":"600-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Influence of 2-(18F) Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography\/Computed Tomography on Recurrent Ovarian Cancer Diagnosis and on Selection of Patients for Secondary Cytoreductive Surgery"],"prefix":"10.1016","volume":"19","author":[{"given":"Signe","family":"Risum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Roed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svend A.","family":"Engelholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Markova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne K.","family":"Berthelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Loft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flemming","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estrid","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/oxfordjournals.annonc.a010602","article-title":"Defining progression of ovarian carcinoma during follow-up according to CA 125; a North Thames Ovary Group study","volume":"7","author":"Rustin","year":"1996","journal-title":"Ann Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0010","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2001.19.20.4054","article-title":"Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels","volume":"19","author":"Rustin","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.2003.01.223","article-title":"Use of CA-125 to assess response to new agents in ovarian cancer trials","volume":"21","author":"Rustin","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Canc Evaluation of er, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0025","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(07)70273-5","article-title":"Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations","volume":"8","author":"Goonewardene","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0030","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1200\/JCO.2005.02.2582","article-title":"Risk of epithelial ovarian cancer recurrence in patients with rising serum CA125 levels within the normal range","volume":"23","author":"Santillan","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0035","first-page":"189","article-title":"Survival of patients following secondary cytoreductive surgery on ovarian cancer","volume":"61","author":"Berek","year":"1983","journal-title":"Obstet Gynecol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygyno.2004.11.057","article-title":"The role of secondary cytoreductive surgery for recurrent ovarian cancer","volume":"97","author":"G\u00fcng\u00f6","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0045","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.20106","article-title":"Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?","volume":"100","author":"Zang","year":"2004","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma","volume":"88","author":"Eisenkop","year":"2000","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","article-title":"Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer","volume":"79","author":"Gadducci","year":"2000","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejso.2004.08.016","article-title":"Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum","volume":"31","author":"Gronlund","year":"2005","journal-title":"Eur J Surg Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2004.09.018","article-title":"Critical evaluation of secondary cytor- eduction in recurrent ovarian cancer","volume":"95","author":"Munkarah","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/GCO.0b013e3280115f40","article-title":"Cytoreductive surgery for recurrent ovarian cancer","volume":"19","author":"Hauspy","year":"2007","journal-title":"Curr Opin Obstet Gynecol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0080","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.2007.11.0932","article-title":"Role of surgery in ovarian carcinoma","volume":"25","author":"Fadder","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0090-8258(03)00336-6","article-title":"Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET\/CT","volume":"90","author":"Bristow","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0090","first-page":"398","article-title":"PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation","volume":"39","author":"Pannu","year":"2004","journal-title":"Abdom Imaging."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00259-006-0260-x","article-title":"Role of [18F]FDG PET\/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings","volume":"34","author":"Chung","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2006.10.060","article-title":"Clinical use of combined positron emission tomography and computed tomography (FDG-PET\/ CT) in recurrent ovarian cancer","volume":"105","author":"Thrall","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0105","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/rct.0b013e31803e8c45","article-title":"Detection of recurrent ovarian cancer at MRI: comparison with integrated PET\/CT","volume":"31","author":"Kim","year":"2007","journal-title":"J Comput Assist Tomogr."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1438.2007.00826.x","article-title":"Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature","volume":"17","author":"Gaducci","year":"2007","journal-title":"Int J Gynecol Cancer."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0115","first-page":"746","article-title":"The value of FDG PET\/CT, ultrasound, and CT in diagnosing recurrent ovarian carcinoma","volume":"77","author":"Grabiec","year":"2006","journal-title":"Ginekol Pol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0120","first-page":"1551","article-title":"Evaluation of CA125, physical, and radiological findings in follow-up of ovarian cancer patients","volume":"25","author":"Fehm","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0125","first-page":"627","article-title":"Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission","volume":"255","author":"Clarke-Pearson","year":"1986","journal-title":"Correlation with surgical-pathologic findings. JAMA."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2214\/ajr.150.4.829","article-title":"CT prior to second-look operation in ovarian cancer","volume":"150","author":"Silverman","year":"1988","journal-title":"AJR Am J Roentgenol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0135","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00004728-199307000-00021","article-title":"CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer","volume":"17","author":"Prayer","year":"1993","journal-title":"J Comput Assist Tomogr."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0140","first-page":"123","article-title":"Computed tomography and second-look surgery in ovarian cancer patients","volume":"16","author":"De Rosa","year":"1995","journal-title":"Eur J Gynaecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0899-7071(98)00023-0","article-title":"Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history","volume":"22","author":"Ferrozzi","year":"1998","journal-title":"Clin Imaging."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0150","first-page":"599","article-title":"Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer","volume":"21","author":"Topuz","year":"2000","journal-title":"Eur J Gynaecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0155","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ygyno.2004.10.045","article-title":"Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma","volume":"96","author":"Mart\u00ednez-Rom\u00e1n","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0160","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2214\/ajr.174.4.1741005","article-title":"FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features","volume":"174","author":"Berger","year":"2000","journal-title":"AJR Am J Roentgenol."},{"key":"10.1111\/IGC.0b013e3181a3cc94_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3747\/co.2007.148","article-title":"Optimal chemotherapy treatment for women with recurrent ovarian cancer","volume":"14","author":"Fung-Kee-Fung","year":"2007","journal-title":"Curr Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181a3cc94","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24039598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24039598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:35:12Z","timestamp":1753101312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24039598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1048891X24039598"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181a3cc94","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of 2-(18F) Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography\/Computed Tomography on Recurrent Ovarian Cancer Diagnosis and on Selection of Patients for Secondary Cytoreductive Surgery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181a3cc94","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}